Pharmafile Logo
Pharmafocus logo
Advanced Search

lilly

Showing 15 posts of 210 posts found.

Lilly image

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

News

Pharma firms give researchers access

July 22, 2014
Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library

 UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …

News
Lilly image

Lilly signs Immunocore deal

July 17, 2014
Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly

Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …

News
Lilly image

Lilly’s Efient tipped for expanded NICE approval

June 20, 2014
Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner

 Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …

News
App image

Lilly app targets depression

June 10, 2014
Medical Communications, Sales and Marketing Android, depression, iphone, lilly, talking progress

Eli Lilly has launched a free mobile app for Android and iPhone handsets which aims to support patients who suffer …

News
Lilly image

Lilly the latest to open up data

June 4, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials

Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …

News
cialis_lilly_sanofi

Cialis OTC approval sought

June 2, 2014
Sales and Marketing Cialis, ED, OTC, Sanofi, lilly

Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …

News
Lilly image

£47.5 million fund for UK life sciences

May 29, 2014
Research and Development, Sales and Marketing European Investment Fund, Scottish Enterprise, Strathclyde Pension Fund, UK, epidarex, life sciences, lilly

A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …

News
Merck image

Merck’s vorapaxar gains long-awaited FDA approval

May 9, 2014
Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …

News

Novartis reports healthy profit

April 25, 2014
Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …

News

GSK and Novartis sign multi-billion dollar deal

April 23, 2014
Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines

GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …

News
takeda__actos__pioglitazone

Takeda and Lilly hit with $9 billion Actos damages bill

April 8, 2014
Medical Communications, Sales and Marketing Actos, Takeda, law case, lilly

A US jury has ordered Japanese firm Takeda Pharmaceutical to pay $6 billion (£3.6 billion) in punitive damages, over claims …

News

Lundbeck teams up with Lieber Institute

April 3, 2014
Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly

Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …

News
GSK image

Europe grants Eperzan licence

March 27, 2014
Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly

The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …

News

CHMP recommends Jardiance

March 24, 2014
Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly

Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024